This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes특발성 뇌전증 및 뇌전증증후군 (국소화-관련)

ICD-10 codeG40.01
Special Copayment Reduction codeV279
Synonyms / related termsFocal idiopathic epilepsy, benign epilepsy with centrotemporal spikes (BECTS/SeLECTS), Panayiotopoulos syndrome, Gastaut-type occipital lobe epilepsy
ClassificationSevere intractable disease (Special Copayment Reduction registration criteria: 5 years)

History

Localization-related idiopathic epilepsy has long been recognized in the history of epileptology as a clinical syndrome with age-related seizure patterns without a structural cause. In 1989, the International League Against Epilepsy (ILAE) formalized the classification of epilepsy as a dual system of "localization-related" versus "generalized" and "idiopathic" versus "symptomatic" versus "cryptogenic," and G40.01 refers to idiopathic epilepsy and epileptic syndromes, localization-related, within this classification.

The best-known subtype is benign childhood epilepsy with centrotemporal spikes (BECTS/BCECTS; now self-limited epilepsy with centrotemporal spikes, SeLECTS); Gibbs and Lennox described the characteristic EEG pattern in the 1950s, and Nayrac and Beaussart established it as a clinical syndrome in 1958. For benign occipital lobe epilepsy, Gastaut described the early-onset form in 1989, and Panayiotopoulos separately described Panayiotopoulos syndrome in 1989.

In the 2017 revised ILAE classification, the concept of "idiopathic" was redefined as genetic etiology, and these syndromes were recognized as mostly self-limited or drug-responsive, with a benign course. With advances in molecular genetics, many causative genes such as PRRT2, KCNQ2, and SCN1A have been identified.

Causes

Localization-related idiopathic epilepsy has genetic predisposition as its main etiology, and a complex genetics or polygenic susceptibility model, rather than single-gene mutation, is understood to predominate. This group of diseases is characterized by epileptogenesis occurring without a structural or metabolic etiology.

For SeLECTS/BECTS, RBFOX1 variants and 16p13 copy number variation have been reported, and a susceptibility locus around the ELP4 gene has been identified. Panayiotopoulos syndrome has been suggested to be associated with SCN1A polymorphisms in some cases. When familial clustering is high, differentiation is needed from chandelier syndrome, in which PRRT2 mutations coexist with migraine and movement disorders.

As environmental factors, sleep deprivation, fever, hyperventilation, and photic stimulation can act as seizure triggers but are not the underlying etiology. If a history of afebrile seizures or brain injury, cortical dysplasia, and the like are present, the classification should be changed to "symptomatic" or "structural."

Genetics

The mode of inheritance of localization-related idiopathic epilepsy is mostly heterozygous complex inheritance, and single-gene autosomal dominant inheritance is confirmed in only a few pedigrees. In SeLECTS, an enhancer region within the ELP4 gene (15q14) has been reported as a susceptibility locus, and linkage studies including it have described pedigrees showing autosomal dominant inheritance.

When accompanied by familial infantile epilepsy and migraine, PRRT2 (19q13.12) mutations should be checked. PRRT2 is a presynaptic protein involved in regulating neurotransmitter release, and loss-of-function variants of this gene form a spectrum combining self-limited infantile epilepsy, paroxysmal kinesigenic dyskinesia, and migraine.

In genome-wide association studies (GWAS), several loci including 16p13, 11p13, and 4p15 have been found to be associated with BECTS risk. Variants in DEPDC5 (an mTOR pathway regulator) produce a phenotype overlapping with focal cortical dysplasia, so a gene panel test is considered for the purpose of differentiation from structural causes.

Epidemiology

Among childhood epilepsies, the localization-related idiopathic form is one of the most common groups. SeLECTS/BECTS accounts for about 15-25% of childhood epilepsy, and the prevalence is estimated at about 10-20 per 100,000. The age of onset is 3-13 years, and a male predominance (male:female = 1.5:1) is reported.

The incidence of Panayiotopoulos syndrome accounts for about 6-17% of epilepsy in children aged 3-6 years, and early-onset occipital lobe epilepsy (Gastaut type) is concentrated at ages 8-17 years. Newly diagnosed localization-related idiopathic forms are rare in adults, and if there is no recurrence after remission in adolescence, most are seizure-free in adulthood.

Domestic epidemiological data are limited, but according to data from the Korean Epilepsy Society and the Health Insurance Review & Assessment Service, the proportion of idiopathic focal epilepsy among pediatric epilepsy patients is about 5-10% of epilepsy patients of all ages. With Special Copayment Reduction (V279) registration, the medical cost burden is reduced as a severe intractable disease.

Pathophysiology

The pathophysiology of localization-related idiopathic epilepsy is understood as the result of age-dependent cortical maturation combined with genetic predisposition. In SeLECTS, centrotemporal spikes originate from hyperexcitability of the perisylvian cortex and resolve spontaneously in adolescence, when myelination and synaptic maturation of this region are complete.

Cortical excitation-inhibition imbalance (E/I imbalance) is the core pathophysiology, with a transient decrease in GABA-mediated inhibition and an increase in glutamate-mediated excitation acting in combination. In particular, reduced function of KCNQ (M-current) channels is known to amplify the afterdepolarization shift after hyperpolarization in cortical neurons.

In Panayiotopoulos syndrome, hyperexcitability of autonomic regulatory circuits within the occipital and occipito-temporal cortex causes autonomic seizures (vomiting, sweating, eye deviation). These circuits are linked with dopaminergic and cholinergic projections and stabilize in an age-dependent manner.

Symptoms

Seizures in SeLECTS begin mainly as sleep-related (during sleep or just after awakening) focal motor seizures, characterized by convulsions of the facial and oropharyngeal muscles (hemifacial spasm, lip twitching), drooling, and speech arrest (anarthria). They may progress to secondary generalization, but consciousness is preserved at first. Todd paralysis after the seizure occasionally accompanies them.

Panayiotopoulos syndrome begins with prominent autonomic symptoms such as nausea and vomiting, pallor, sweating, and pupillary abnormalities, and eye deviation is common. Seizure duration is long (several minutes to 30 minutes), and a postictal stupor may persist. Occipital spike-and-wave complexes are observed on the interictal EEG.

In Gastaut-type occipital lobe epilepsy, visual symptoms (photopsia, scotoma, polychromatopsia) are prominent as the initial seizure symptoms, accompanied by headache and nausea, requiring differentiation from migraine. Seizure duration is short and progression to secondary generalization is common.

Signs

The absence of abnormal findings on neurological examination in the interictal period (outside the ictal period) is an important feature of idiopathic epilepsy. Because there is no structural lesion, focal neurological deficits, signs of raised intracranial pressure, and neurocutaneous abnormalities are not expected.

Immediately after a seizure, Todd paralysis, transient language impairment, and visual field defects may persist for several minutes to several hours but recover completely. On neurocognitive evaluation, mild decreases in attention, verbal fluency, and memory have been reported in some SeLECTS patients, but these are within the developmentally normal range or recover after remission.

During a seizure, increased heart rate, blood pressure fluctuation, and decreased oxygen saturation may be observed, and autonomic seizures are especially prominent in Panayiotopoulos syndrome. These autonomic changes can be recorded when a seizure occurs during long-term video-EEG monitoring (VEEG).

Screening

Standard electroencephalography (EEG) is the most important screening tool. In SeLECTS, centrotemporal spikes or spike-and-wave complexes (rolandic spikes) are activated during sleep, and the background activity is normal. Sleep-deprived EEG, including hyperventilation and photic stimulation activation tests, is recommended.

Video-EEG monitoring (VEEG) is useful for confirming seizure patterns, localizing the seizure origin, and recording autonomic changes during seizures. 24-hour long-term EEG monitoring (ambulatory EEG) is used to capture seizures during sleep in the outpatient setting.

Blood tests (complete blood count, electrolytes, blood glucose, liver and kidney function, thyroid function) are performed at initial evaluation to exclude symptomatic causes. An epilepsy gene panel is considered when there is a positive family history, an atypical course, or treatment resistance.

Diagnosis

The diagnosis is based on comprehensive judgment of clinical symptoms, EEG findings, and imaging. According to the 2017 ILAE classification, diagnosis of localization-related idiopathic (genetic) epilepsy requires ① a focal seizure pattern, ② conformity to an age-specific epilepsy syndrome, ③ normal brain MRI (exclusion of structural etiology), and ④ characteristic EEG findings.

Brain MRI should exclude structural abnormalities with a high-resolution protocol of 1.5T or higher (FLAIR, T1 volumetric, DWI). If MRI is normal and clinical-EEG findings are typical, a clinical diagnosis is possible without further testing. In an atypical course or drug resistance, consider adding 3T MRI or FDG-PET.

Cerebrospinal fluid examination is performed only when autoimmune encephalitis or infectious epilepsy is suspected. Neuropsychological testing is useful for assessing comorbid cognitive problems such as learning disorder and attention deficit, and for follow-up. For Special Copayment Reduction registration, submission of a specialist (neurology or pediatric neurology) diagnosis certificate, EEG report, and MRI reading report is required.

Treatment

SeLECTS/BECTS shows a self-limited course, so when seizure frequency is low and seizures occur only during sleep, an observation strategy of withholding treatment is possible. The treatment decision comprehensively considers seizure frequency, presence of daytime seizures, interference with school life, and the degree of caregiver anxiety.

When drug treatment is chosen, the first-line drugs are oxcarbazepine or carbamazepine, and levetiracetam and valproate are also used. The dose is determined on a weight basis and is gradually reduced after maintenance for 2 years following seizure freedom.

In Panayiotopoulos syndrome, seizures are infrequent and self-limited, so antiseizure medication (ASM) is not necessarily required. However, when seizure duration is long and there is a risk of status epilepticus (SE), a seizure action plan is established that includes prescribing home midazolam (buccal) or diazepam (rectal) for seizure termination.

Non-drug treatments such as the ketogenic diet, vagus nerve stimulation (VNS), and responsive neurostimulation (RNS) are considered only when drug resistance is confirmed, and are rarely applied in idiopathic forms.

Prognosis

Localization-related idiopathic epilepsy generally has a good prognosis. SeLECTS remits spontaneously before age 16 in more than 97%, and recurrence in adulthood is extremely rare. The prognosis is better when seizures occur only during sleep.

However, in some patients neurocognitive problems such as learning disorder, language disorder, attention-deficit/hyperactivity disorder (ADHD), and reading disorder may persist during treatment or after remission. These are related to the non-ictal effects of centrotemporal discharges on language-cognitive networks rather than to the seizures themselves.

Panayiotopoulos syndrome and Gastaut-type occipital lobe epilepsy also mostly remit in adolescence, but in some, focal or generalized seizures may persist into adulthood. A history of status epilepticus, developmental delay, and atypical EEG findings are poor prognostic factors.

Prevention

Because it is a disease due to genetic predisposition, primary prevention is not possible. However, seizure frequency can be reduced by minimizing seizure triggers. Maintaining regular sleep habits, preventing sleep deprivation, and limiting excessive screen exposure (photic stimulation) are recommended.

For secondary prevention of seizures, it is important to take the prescribed antiseizure medication regularly and not stop it arbitrarily. Education on seizure first aid (seizure action plan) is provided to patients, caregivers, and teachers so that appropriate management is given if a seizure persists.

Through regular outpatient neurology follow-up (at 6-12 month intervals), seizure control, drug adverse effects, and neurocognitive development are checked. Take care not to miss renewal (every 5 years) after Special Copayment Reduction registration, and provide guidance on safety-related activities such as driving and swimming even after remission.

References

  1. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010;51(4):676-685. PMID: 20196795
  2. Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512-521. PMID: 28276062
  3. Specchio N, Wirrell EC, Scheffer IE, et al. International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood. Epilepsia. 2022;63(6):1398-1442. PMID: 35503717
  4. Bouma PA, Bovenkerk AC, Westendorp RG, Brouwer OF. The course of benign partial epilepsy of childhood with centrotemporal spikes: a meta-analysis. Neurology. 1997;48(2):430-437. PMID: 9040737
  5. Panayiotopoulos CP. Panayiotopoulos syndrome: a common and benign childhood epileptic syndrome. Brain Dev. 2004;26(5):281-291. PMID: 15165027
  6. Guerrini R, Pellacani S. Benign childhood focal epilepsies. Epilepsia. 2012;53(Suppl 4):9-18. PMID: 22946718
  7. Lemke JR, Lal D, Reinthaler EM, et al. Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet. 2013;45(9):1067-1072. PMID: 23933819
  8. Coppola G, Plouin P, Chiron C, Robain O, Dulac O. Migrating partial seizures in infancy: a malignant disorder with developmental arrest. Epilepsia. 1995;36(10):1017-1024. PMID: 7555938
  9. Janz D. The idiopathic generalized epilepsies of adolescence with childhood and juvenile age of onset. Epilepsia. 1997;38(1):4-11. PMID: 9024183
  10. Kim YO, Kang HC, Kim HD. Antiepileptic drug treatment of benign epilepsy with centrotemporal spikes in Korean children. J Korean Child Neurol Soc. 2014;22(3):143-148. DOI: 10.26815/jkcns.2014.22.3.143